CATO PHARMA ApS: Financial statements 2019
CVR: 33949596
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
CATO PHARMA ApS (CVR 33949596) has filed annual accounts for 2019. In 2019, the company reported a net result of DKK -588 compared with DKK -5,518 the year before. Equity in the 2019 report amounted to DKK -279,974.
- Profit/Loss
- DKK -588
- Equity
- DKK -279,974
- Total Assets
- DKK 4,377
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | - | -588 | -280 t. | - |
| 2018 | - | - | -6 t. | -279 t. | - |
| 2017 | 0 | 0 | -539 | -274 t. | - |
| 2016 | 0 | -750 | -848 | -273 t. | - |
| 2015 | - | -5 t. | -13 t. | -272 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
CATO PHARMA ApS has published its annual report for 2018. The net result was DKK -5,518.
About CATO PHARMA ApS
CATO PHARMA ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2011. The company has been dissolved. The company was registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. In 2024, the company reported a net result of DKK -1,668 compared with DKK -1,588 the year before. Equity in the 2024 report amounted to DKK -283,700.